Biotechnology News

January 2, 2013

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS® (apixaban) to reduce the risk of stroke and...

January 2, 2013

EMERYVILLE, Calif.--(BUSINESS WIRE)--Human Genome Interpretation Company Omicia Appoints Mike Aicher as CEO

January 2, 2013

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the 31st Annual J.P. Morgan Healthcare Conference on Monday, January 7, at 3:00 p.m. Pacific Standard Time. The conference...

January 2, 2013

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) will host a conference call to discuss its commercialization plan for Gattex, including the cost of therapy, today at 5:00 p.m. Eastern Time. To participate in the...

January 2, 2013

LAKE FOREST, Calif.--(BUSINESS WIRE)--Cryoport, Inc. (OTCBB:CYRX) today announced that Chief Executive Officer Jerrell Shelton is scheduled to present at the Biotech Showcase on Monday, January 7, 2013 at 9:00 a.m. Pacific time. The conference is...

January 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the 31st Annual J.P. Morgan Healthcare Conference being held in San Francisco. Harvey J. Berger, M.D., chairman and chief...

January 2, 2013

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration has approved Fulyzaq™ (crofelemer) 125 mg delayed-release tablets for the symptomatic relief of non-infectious...

January 2, 2013

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) today announced that the European Commission granted orphan medicinal product designation to Emergent’s humanized single chain monoclonal antibody against CD37, also called...

January 2, 2013

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals will present overview of the Company's business strategy and commercial and development-stage programs at the 31st Annual J.P. Morgan Healthcare Conference.

January 2, 2013

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that it will present at the 31st J.P. Morgan Healthcare Conference on Monday, January 7, 2013, at 11:30 a.m. Pacific Time at the Westin St. Francis Hotel in San...

January 2, 2013

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at The 31st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 9, 2013 at 4:30 p.m. PT (7:30...

January 2, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Daniel Junius,...

January 2, 2013

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced the appointment of Gary S. Titus to its board of directors. Mr. Titus is currently the Senior Vice President and Chief Financial...

December 31, 2012

AUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below. On Tuesday,...

December 31, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based electronic health record (EHR), practice management, and care coordination services to medical groups and health systems, made significant...

December 31, 2012

IRVINE, Calif.--(BUSINESS WIRE)--InnovoCommerce announces innovoPOINT cSafety Exchange™, a compelling new virtual private cloud-based solution for secure and compliant safety report distribution, management and reporting.

December 31, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences to raise $2.8 Million pursuant to Securities Purchase Agreement. Funds are earmarked for Soltamox commercial activities, Gelclair launch and working capital.

December 31, 2012

ST. LOUIS--(BUSINESS WIRE)--Mallinckrodt, the Pharmaceuticals business of Covidien (NYSE: COV), today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market a generic version of CONCERTA...

December 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the J.P. Morgan 31st Annual Healthcare Conference on January 7, 2013, at 10:00 a.m. ET in San Francisco, CA. A live webcast of this Infinity...

December 28, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS® (apixaban)

December 28, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has signed a license agreement with VaxInnate Corporation under which Emergent acquired the exclusive right to manufacture and sell VaxInnate’s...

December 28, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: The number of shares and votes in Orexo (STO:ORX) has changed as a result of the exercise of warrants. Today, the last trading day of the month, there are in total 29,946,332 shares and votes in...

December 28, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present at the upcoming 31st Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2013 at 11:00 a.m...

December 27, 2012

GERMANTOWN, Wis.--(BUSINESS WIRE)--Global pharmaceutical chemistry services leader, Cambridge Major Laboratories, Inc. (“CML”) announced today that it has taken on a new private equity partner, American Capital, Ltd. (Nasdaq: ACAS) (“American...

December 27, 2012

GREAT NECK, N.Y.--(BUSINESS WIRE)--Brain & Behavior Research Foundation (formerly National Alliance for Research on Schizophrenia and Depression/NARSAD) presents 10 highlights of 2012; mental illness breakthroughs by NARSAD Grantees.

December 27, 2012

SAVANNAH, Ga.--(BUSINESS WIRE)--John Norris, JD, MBA Appointed CEO of Health Discovery Corporation

December 27, 2012

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--BASi (Bioanalytical Systems, Inc.) (NASDAQ:BASI) today announced the launch of Culex® NxT, the latest generation of the Company’s proprietary in vivo automated sampling system. The Company is now taking...

December 27, 2012

NEW YORK--(BUSINESS WIRE)--Retrophin (OTCQB: RTRX), a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases, today announced that Martin Shkreli, Founder & Chief Executive Officer, will...

December 27, 2012

SAN DIEGO--(BUSINESS WIRE)--CE Mark for VerifyNow II System Caps a Strong 2012 for Accumetrics. Clinical Data, Guideline Recommendations and Cost Effectiveness Study Strengthen Clinical Need for Platelet Reactivity Testing.

December 27, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that it has...

December 27, 2012

BUENA, N.J.--(BUSINESS WIRE)--IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it closed a private placement on December 21, 2012 for a gross proceeds of $2.0 million. The Company...

December 27, 2012

TORONTO--(BUSINESS WIRE)--The North American facial Injectables market, comprising botulinum toxin (BTX) and dermal fillers sold in the United States and Canada, will continue to show strong growth for the next five years.

December 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2013 at...

December 26, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ:KYTH) today announced that the company has been added to each of the broad-market Russell 3000® Index, the Russell 2000® Index, the Russell Microcap® Index and the Russell...

December 26, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel announces preliminary agreement to sell NovaMist technology to Australian company, SUDA Ltd.

December 26, 2012

MIAMI--(BUSINESS WIRE)--OPKO Health to Expand Latin American Presence with Acquisition of Brazilian Pharmaceutical Company

December 26, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group and AMR in their TreatmentTrends®: Pneumonia (U.S.) report find that for the management of nosocomial pneumonia (NP), the most commonly cited change in treatment practices of surveyed...

December 26, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, AMAG’s chief executive officer, will present at the 31st Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2013 at 8...

December 26, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Celator® Pharmaceuticals Enrolls First Patient in Its Phase 3 Study of CPX-351 in Untreated High-Risk Acute Myeloid Leukemia

December 26, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved ELIQUIS® (apixaban) for the prevention of...

December 26, 2012

DENVER--(BUSINESS WIRE)--Summarizes a banner year for DaVita, a leading kidney care/dialysis company, in 2012.

December 26, 2012

DUBLIN--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced a definitive agreement to acquire CV Ingenuity.

December 26, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen, Inc. today announced its ARGUS® Whole Genome Mapping System technology was used in combination with next-generation sequencing (NGS) to produce the first, high-quality reference genome of the domestic...

December 24, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. received the final $2.5M tranche of a total $5M raise announced in June 2012. The funding came from a single investor, namely, Seaside 88, LP.

December 24, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardio renal disease, announced that it...

December 24, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it has submitted a supplemental new drug application (sNDA) to the United States Food and Drug Administration (FDA) for Feraheme® (ferumoxytol)...

December 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that the company amended its development and license agreement with Millennium: The Takeda Oncology Company and Takeda Pharmaceutical Company Limited...

December 21, 2012

SEATTLE--(BUSINESS WIRE)--Dr. Leroy Hood was awarded the National Medal of Science in recognition of his visionary work in science and engineering. He is a world-renowned scientist, inventor, and entrepreneur.